Funded Startups in Jerusalem
Among the 43 most recent funded startups listed for Jerusalem, the largest disclosed round is VISIONIX at $220M (2026-04-13), which dwarfs the next-largest…
Among the 43 most recent funded startups listed for Jerusalem, the largest disclosed round is VISIONIX at $220M (2026-04-13), which dwarfs the next-largest disclosed amounts that cluster far lower (e.g., OrCam Technologies at $181M on 2024-07-28 and Future Meat at $347M on 2021-12-17). Sector and timing also show clustering: “Series Unknown” appears in 17 of 43 rows, and the list spans 2020-02-26 (Strattic, $7M) through 2026-06-16 (Splisense, $13M), with multiple entries in 2026 alone (e.g., Splisense $13M on 2026-06-16; Adenocyte $10M on 2026-05-26; Entera Bio $10M on 2026-04-02). Several biotech-linked startups recur (Biotechnology appears in 11+ rows, including Splisense $13M on 2026-06-16; Nectin Therapeutics $10M on 2024-05-06; Future Meat $347M on 2021-12-17), while undisclosed amounts show up as a recurring data gap (undisclosed appears in 6 of 43 rows).
Most recent rounds
43 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Jerusalem list, and how extreme is it versus the rest?
Future Meat’s $347M (2021-12-17) is the clear top disclosed amount, materially above the next-largest disclosed rounds in the table, including VISIONIX at $220M (2026-04-13) and OrCam Technologies at $181M (2024-07-28).
Is there a “data gap” pattern in round sizing or stage labels?
“Series Unknown” shows up in 17 of 43 rows, and undisclosed amounts appear in 6 of 43 rows (for example AccuBeat on 2025-10-10 and Joyned on 2023-12-14). Together, they limit how much of the dataset can be compared by stage and disclosed size.
Do startups cluster in time near the top of the list (recent months/quarter)?
Yes. In 2026 alone, three consecutive rounds in the table are between 2026-04-02 and 2026-05-26 (Entera Bio $10M on 2026-04-02; VISIONIX $220M on 2026-04-13; Adenocyte $10M on 2026-05-26), followed by Splisense $13M on 2026-06-16.
Which sectors are over-represented compared to the rest of the table?
Biotechnology appears in 11+ entries across the date range, including Splisense ($13M, 2026-06-16), Nectin Therapeutics ($10M, 2024-05-06), and Future Meat ($347M, 2021-12-17). AI also shows multiple entries (e.g., OrCam Technologies $181M on 2024-07-28; Neteera $13M on 2023-04-12), but Biotechnology is the clearest concentration by count.
Are there outliers where the category or disclosed size doesn’t fit the dominant pattern?
Several. Future Meat’s $347M (2021-12-17) is far above typical disclosed sizes in the list (many rounds sit around single-digit millions, such as MagniLearn $3M on 2021-10-19). On the other end, several very small disclosed rounds appear as floor-level datapoints, including $30K entries for GynTools (2024-06-06) and Hydro X (2024-06-06).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.